Catalera BioSolutions
PrivateLast Round
Grant
Oct 22, 2026
Total Funding Raised
$8.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Catalera BioSolutions operates in Healthcare & Life Sciences and is based in Vancouver. Its latest recorded funding round was a Grant round in October 2026.
Catalera BioSolutions is a biotechnology company that develops and commercializes biological solutions for pest control in plant, home, and public health sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Catalera BioSolutions Comparables
Compare Catalera BioSolutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Terramera | 81% | |
| Ascribe Bio | 78% | |
| BioCloak | 76% |
For institutional investors. Book with your work email.
Catalera BioSolutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 22, 2026 | ||||
| Series A | Sep 10, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Catalera BioSolutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Farm Credit Canada (FCC) Capital | Series A |
| S2G Investments | Series A |
| Natural Products Canada | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 22, 2026
$100K raised from Natural Products Canada.
- Sep 10, 2024
$8M round led by S2G Investments.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingOct 22, 2026
Catalera BioSolutions Inc. receives $99K in Proof of Concept financing from Natural Products Canada on Oct 22nd '26 to evaluate its natural wax-based seed-coating technology under Canadian agronomic conditions.
For institutional investors. Book with your work email.
Catalera BioSolutions Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Catalera BioSolutions's valuation, stock price, and market status.
Is Catalera BioSolutions a public or private company?
Catalera BioSolutions is a private company.
What is the current stock price of Catalera BioSolutions?
Catalera BioSolutions is a private company, so its shares have no public market price. Caplight tracks Catalera BioSolutions's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Catalera BioSolutions worth (valuation)?
Valuation information for Catalera BioSolutions is not publicly available.
Can I buy Catalera BioSolutions stock?
Catalera BioSolutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Catalera BioSolutions's last funding round?
Catalera BioSolutions's most recent funding round was Grant on October 22, 2026.
Who are the main investors in Catalera BioSolutions?
Key investors in Catalera BioSolutions include S2G Investments.
Will Catalera BioSolutions IPO soon?
No public IPO plans have been announced for Catalera BioSolutions.
How can I track Catalera BioSolutions secondary market activity?
Caplight tracks bids, offers, and trades in Catalera BioSolutions's shares on secondary markets.